Sun, Dec 28, 2014, 5:33 AM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Spectrum Pharmaceuticals, Inc. Message Board

bhakes_98 35 posts  |  Last Activity: Dec 25, 2014 9:50 AM Member since: Jan 5, 1999
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Watch What Happens Next Several Weeks !

    by eby331vm Dec 24, 2014 9:17 PM
    bhakes_98 bhakes_98 Dec 25, 2014 9:50 AM Flag

    I have thought the same thing - but I remind myself the float is well below 20MM shares. With good growth and news, it will be difficult to sustain a walk down as investors (institutional) will buy up the shares.

    I think the big risk here is if a retail investor is out of a position. Even at $10 pps the market cap is only $250MM, with distributors in 28 countries and a US FDA trial announcement up coming - I don't see why the market cap can't run up to a billion dollars near term. CTSO can be an easy double from here.

    A blessed Christmas to all!

  • bhakes_98 bhakes_98 Dec 23, 2014 10:40 AM Flag

    Today CTSO uplisted to NASDAQ. Because of the 1:25 reverse split, CTSO has about 1/2 as many shares as SCLN. Unlike SCLN it sells the filter in many countries and is not just China focus. The revenue potential, growth, is far greater than SCLN. CTSO has also singed Fresinius as a partner.

    While SCLN spoke of using Z for sepsis treatment , CTSO is reporting positive results (case studies) of hemo filtration applied to Sepsis patients. When I hear Blobel talk of using Z for Sepsis, I remember the failed trials SCLN has undertaked and the ST brothers saying the company should not be the sole sponsor of clinical trials or at least phase three trials. While sepsis is an unmet medical need and the market for a remedy is indeed huge - Blobel's comment just makes me think here we go again.

    Long ago I asked bertha if he still had any SCLN in his portfolio and he said he sold it all. I still have a position in SCLN but a much larger one in CTSO.

  • Reply to


    by thegetdoor Dec 22, 2014 8:21 PM
    bhakes_98 bhakes_98 Dec 23, 2014 9:18 AM Flag

    $50 pps, that sounds like a lot, a ten-bagger or so, but it is still a market cap of about $1.5 billion. I consider that miniscule considering the future of potential sales.

  • bhakes_98 bhakes_98 Dec 19, 2014 2:54 PM Flag

    No dialysis machines will be in the OR - it is a machine dedicated for the purpose of taking over the process of pumping the blood of the and monitoring patient vital signs. A dialysis machine is not dedicated to pumping blood.

  • Reply to

    Zack's comment on CTSO's....

    by bhakes_98 Dec 18, 2014 10:37 AM
    bhakes_98 bhakes_98 Dec 18, 2014 10:46 AM Flag

    Up-listing Dec, 23rd, a Christmas present from Dr. Chan!

  • marketing strategy.

    "....we view management’s marketing and awareness building strategy, which is based on clinical successes and evidence and not on a “just trust me” sales pitch, as having the greatest potential to drive demand for CytoSorb. And based on the rapid product sales growth (7 straight quarters of product revenue growth) and consummation of high-potential distribution agreements, we think it’s fair to conclude that this strategy is paying significant dividends. This deal with Fresenius is one which we think speaks particularly loud to CTSO’s successes and the growing confidence in the utility of CytoSorb."

    With 23MM shares outstanding, less the closely held shares, CTSO probably has less than 20mm shares in float. When we complete the uplisting, in early January at the latest, the institutional money will start to drive up the PPS. Who knows how high this will go.

  • Reply to

    Question regarding analysts/

    by baroque_oboe_man Dec 11, 2014 3:13 PM
    bhakes_98 bhakes_98 Dec 12, 2014 12:20 AM Flag

    The CE approval was granted because the filter did what it was suppose to do; be safe and reduce cytokines.

    Furthermore, CTSO will announce (soon) they have submitted an application to the FDA for a trial using the filter in Cardiac Bypass Surgery. That should get peoples attention especially since its use for that purpose has been well received in Germany.

  • bhakes_98 bhakes_98 Dec 10, 2014 11:26 AM Flag

    bchayes - I have been long as well but my position isn't as large as it once was but it is now all "house money." Bertha is over on the CTSOD board where they post research much like what they did for SCLN.

  • Reply to

    99.9 percent

    by dgh1027 Dec 9, 2014 12:21 PM
    bhakes_98 bhakes_98 Dec 9, 2014 11:03 PM Flag

    Stocks go up, stocks go down happens 100% of the time.

  • bhakes_98 by bhakes_98 Dec 5, 2014 5:17 PM Flag

    from today's PR regarding the Romanian distributorship; "In this early phase of our relationship we already have experienced amazing therapeutic results by applying CytoSorb® Therapy to patients who suffered from extremely life-threatening critical illnesses. We are proud to have demonstrated our ability to work with Romanian thought leaders in this field and foresee an impressive development of the therapy as a whole."

  • Reply to


    by patientd1 Dec 5, 2014 12:13 PM
    bhakes_98 bhakes_98 Dec 5, 2014 5:02 PM Flag

    Of course it's a generational thing, we didn't have computers much less a message board.

  • Reply to


    by berthabluefish Dec 5, 2014 8:47 AM
    bhakes_98 bhakes_98 Dec 5, 2014 9:08 AM Flag

    Yes, up $2.30 from last December!

  • bhakes_98 bhakes_98 Dec 2, 2014 7:58 PM Flag

    The company just keeps moving forward. Albeit slower than what some would like but this is a new industry unfolding as we watch.

  • Reply to

    Paid bashers

    by petryandre33 Nov 29, 2014 7:45 AM
    bhakes_98 bhakes_98 Nov 29, 2014 11:04 AM Flag

    Add to that scenario the number of share's outstanding will be 23,262,801. I estimate that about one quarter of those shares are closely held, so that would leave about 16 to18 million in float. With even minor interest from institutions the price should not only hold up but also appreciate. With institutions bidding up the price, CTSO can issue more stock for equity financing.

    Considering that analyst are projecting a 50 cent pre PPS, institutions pursuing a reduced share count could be the means to get the post PPS to $12.5.

  • Reply to


    by sin_nickle1 Nov 27, 2014 10:53 AM
    bhakes_98 bhakes_98 Nov 27, 2014 9:14 PM Flag

    That was funny - thanks for the chuckle!

  • Reply to

    Post split float

    by bhakes_98 Nov 21, 2014 2:08 PM
    bhakes_98 bhakes_98 Nov 22, 2014 12:00 AM Flag

    It's in the works.

    Relative to the planned U.S. cardiac surgery study, on the Q3 call management reiterated previous expected timelines that they think they will have an IDE submitted by the current year end and hope to commence the study next year.

  • Reply to

    Post split float

    by bhakes_98 Nov 21, 2014 2:08 PM
    bhakes_98 bhakes_98 Nov 21, 2014 11:53 PM Flag

    Thanks Tony - I got my 2016 time frame from a statement I read. But as luck would have it, as I was trying to research it, I can't seem to find that source of that statement.

  • Reply to

    Post split float

    by bhakes_98 Nov 21, 2014 2:08 PM
    bhakes_98 bhakes_98 Nov 21, 2014 11:48 PM Flag

    As always, thanks Ping. The Yahoo data matches the issued and outstanding shares of common stock - but yahoo shows a difference of about 200 million shares between that and the float which can be regarded as closely held shares. I don't know how/who compiles the float data, but I estimate that it is well below 20MM.

    I am sure there are a lot of retail investors who have and will continue to hold positions so institutional investors will have to bid the up the price to get some of those shares. With 23MM share outstanding, I wonder why the BOD decided to go with such a small share count - it seems to be pretty illiquid, even if they do sell a few million more shares after the up-listing.

  • bhakes_98 by bhakes_98 Nov 21, 2014 2:08 PM Flag

    I don't know for sure but i expect that the float post split will be 15MM to 16MM shares. Since CTSO has cash to get it through to 2016 I don't see the need for further dilution associated with equity financing. So when institutional investors want to buy shares they'll have to bid up the PPS.

  • Reply to

    Everything will be fine

    by ipaidtoomuch Nov 20, 2014 3:01 PM
    bhakes_98 bhakes_98 Nov 20, 2014 4:31 PM Flag

    That depends on how old you are.

6.97+0.07(+1.01%)Dec 26 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.